Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RENEW-CKD: HRS-7535 in Chronic Kidney Disease
NCT07625774Phase 3Not yet recruiting
- Sponsor
- Shandong Suncadia Medicine Co., Ltd.
- Start
- Jul 2026
- Primary completion
- May 2031
- Countries
- 1
01
Overview
A Phase 3 trial of HRS-7535 in chronic kidney disease (CKD), sponsored by Shandong Suncadia Medicine Co., Ltd.. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
HRS-7535
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT07625774.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07625774.